Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by bfwon Apr 17, 2019 5:57pm
71 Views
Post# 29641166

RE:RE:RE:RE:RE:RE:RE:RE:JPM

RE:RE:RE:RE:RE:RE:RE:RE:JPMSanders will not get elected in the US.

He’s a joke!

bfw


palinc2000 wrote: When the market perceives that Sanders could be the next President ALL stocks will bew going down
TH is more than 50 % off the 52 week high and IDB is 16.5% off the 52 week high
I see ZERO correlation between TH and IDB

Luc and Philippe were succesful in olacing 100 000 shares from House 222 in friendly hands the day before yesterday but are unable to find a home for more,,,,,
Like I said before the last CC was great except for the lack of guidance ,
Why on earth cant Luc prodide guidance at least for the coming quarter,Yiu stated that March sales were 50% higher than December sales and even though the CC took placein April Luc does not have the condidence to guide for the next 6 weeks.....Dont blame Sanders ,nor analysts nor House 222 ....the buck stops somewhere else


SPCEO1 wrote: All of biotech is getting ripped today with the XBI off over 4%  today and down just shy of 10% over the last 8 trading days. Apparently worried about a single payer health care plan happening under Bernie Sanders or one of the other Democrats. I doubt that happens but the market is going to fuss about it for a while.

muslix1 wrote: Who knows how much remains to sell for JPM thousands or millions...

 




Bullboard Posts